drugset / Trial / NCT00191230

Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer

NCT00191230 ↗

Phase 2 Completed 70 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

To study the efficacy and tolerability of gemcitabine/platinum chemotherapy in non small cell lung cancer

Timeline

Start
2001-09
Primary completion
—
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Carboplatin Small molecule — —
Subject Cisplatin Other / unclassified — —
Subject Gemcitabine Small molecule — —